BNP PARIBAS FINANCIAL MARKETS

Holdings History for Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

Symbol: AXSM on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.04%	0%	$55,593,424	304,388	0		$182.64	Q4 2025
30 Sep 2025	0.02%	0%	$23,088,374	190,106	0		$121.45	Q3 2025
30 Jun 2025	0.02%	0%	$19,462,158	186,437	0		$104.39	Q2 2025
31 Mar 2025	0.02%	0%	$21,300,370	182,632	0		$116.63	Q1 2025
31 Dec 2024	0.01%	0%	$15,708,777	185,661	0		$84.61	Q4 2024
30 Sep 2024	0%	0%	$1,234,185	13,733	0		$89.87	Q3 2024
30 Jun 2024	0%	0%	$643,678	7,996	0		$80.50	Q2 2024
31 Mar 2024	0.01%	0%	$6,587,011	82,544	0		$79.80	Q1 2024
31 Dec 2023	0%	0%	$1,550,174	19,477	0		$79.59	Q4 2023
30 Sep 2023	0%	0%	$1,869,278	26,746	0		$69.89	Q3 2023
30 Jun 2023	0%	0%	$981,967	13,665	0		$71.86	Q2 2023
31 Mar 2023	0%	0%	$966,032	15,662	0		$61.68	Q1 2023
31 Dec 2022	0%	0%	$736,052	9,543	0		$77.13	Q4 2022
30 Sep 2022	0%	0%	$702,140	15,736	0		$44.62	Q3 2022
30 Jun 2022	0%	0%	$389,166	10,161	0		$38.30	Q2 2022
31 Mar 2022	0%	0%	$1,231,601	29,756	0		$41.39	Q1 2022
31 Dec 2021	0.01%	0%	$2,729,681	72,252	0		$37.78	Q4 2021
30 Sep 2021	0%	0%	$217,833	6,609	0		$32.96	Q3 2021
30 Jun 2021	0%	0%	$237,729	3,524	0		$67.46	Q2 2021
31 Mar 2021	0%	0%	$355,913	6,286	0		$56.62	Q1 2021
31 Dec 2020	0%	0%	$427,555	5,248	0		$81.47	Q4 2020
30 Sep 2020	0%	0%	$467,044	6,555	0		$71.25	Q3 2020
30 Jun 2020	0%	0%	$111,078	1,350	0		$82.28	Q2 2020
31 Mar 2020	0.01%	0%	$2,981,740	50,684	0		$58.83	Q1 2020
31 Dec 2019	0%	0%	$347,600	3,363	0		$103.36	Q4 2019
30 Sep 2019	0%	0%	$88,348	4,365	0		$20.24	Q3 2019
30 Jun 2019	0%	0%	$4,146	161	0		$25.75	Q2 2019
31 Mar 2019	0%	0%	$43	3	0		$14.33	Q1 2019
31 Dec 2018	0%	0%	$8	3	0		$2.67	Q4 2018
30 Sep 2018	0%	0%	$10	3	0		$3.33	Q3 2018
30 Jun 2018	0%	0%	$10	3	0		$3.33	Q2 2018
31 Mar 2018	0%	0%	$7	3	0		$2.33	Q1 2018
31 Dec 2017	0%	0%	$17	3	0		$5.67	Q4 2017
30 Sep 2017	0%	0%	$17	3	0		$5.67	Q3 2017
30 Jun 2017	0%	-0%	$17	3	-66	-96%	$5.67	Q2 2017
31 Mar 2017	0%	-0%	$269	69	-154	-69%	$3.90	Q1 2017
31 Dec 2016	0%	-0%	$1,505	223	-533	-71%	$6.75	Q4 2016
30 Sep 2016	0%	+0%	$5,957	756	+316	+72%	$7.88	Q3 2016
30 Jun 2016	0%	+0%	$3,318	440	+440	NEW	$7.54	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.